Article
Boston-An injectable tissue-augmenting material is a promising alternativefor the endoscopic treatment of vesicoureteral reflux in children, accordingto researchers from Dublin, Ireland. At follow-up of up to 1 year, refluxwas corrected in 86% of ureters after a single injection of the material,dextranomer/hyaluronic acid copolymer (Deflux, Q-Med, Uppsala, Sweden),according to lead author Prem Puri, MD, pediatric surgeon and director ofresearch at the National Children Hospital in Dublin.
FDA approves oral sulopenem for uncomplicated urinary tract infection